SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-048646
Filing Date
2024-04-26
Accepted
2024-04-26 07:00:04
Documents
8
Period of Report
2024-06-19

Document Format Files

Seq Description Document Type Size
1 DEF 14A itrm_def_proxy_agm_2024.htm DEF 14A 690036
2 GRAPHIC img247041948_0.jpg GRAPHIC 6275
3 GRAPHIC img247041948_1.jpg GRAPHIC 2403
4 GRAPHIC img247041948_2.jpg GRAPHIC 11646
5 GRAPHIC img247041948_3.jpg GRAPHIC 142505
6 GRAPHIC img247041948_4.jpg GRAPHIC 150695
7 GRAPHIC img247041948_5.jpg GRAPHIC 826740
8 GRAPHIC img247041948_6.jpg GRAPHIC 744269
  Complete submission text file 0000950170-24-048646.txt   3286964
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38503 | Film No.: 24878522
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)